✦ LIBER ✦

Progressive neurologic disability in methylmalonic acidemia despite transplantation of the liver

✍ Scribed by William L. Nyhan; Jay J. Gargus; Karen Boyle; Rick Selby; Richard Koch

Publisher: Springer
Year: 2002
Tongue: English
Weight: 60 KB
Volume: 161
Category: Article
ISSN: 0340-6997
DOI: 10.1007/s00431-002-0970-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Transient elastography in the early pred

Transient elastography in the early prediction of progressive recurrent hepatitis C following liver transplantation

✍ Cristina Rigamonti; Maria Francesca Donato; Massimo Colombo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB 👁 2 views

I read with great interest the article by Das et al. 1 Although presence of nonalcoholic fatty liver (NAFL) in nonobese individuals is a fairly common observation in India, this is the first such scientific documentation for the same. However, I would like to make a few points in this regard. First

The difference in the fibrosis progressi

The difference in the fibrosis progression of recurrent hepatitis C after live donor liver transplantation versus deceased donor liver transplantation is attributable to the difference in donor age

✍ Nazia Selzner; Nigel Girgrah; Les Lilly; Maha Guindi; Markus Selzner; George The 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 227 KB 👁 1 views

Hepatitis C recurs universally after liver transplantation (LT). Whether its progression differs after live donor liver transplantation (LDLT) and deceased donor liver transplantation (DDLT) is still debated. We retrospectively analyzed 201 consecutive LTs performed at our institution for hepatitis

Factors influencing the progression of f

Factors influencing the progression of fibrosis in patients with recurrent hepatitis C after liver transplantation under antiviral therapy: A retrospective analysis of 939 liver biopsies in a single center

✍ Thomas Walter; Jérôme Dumortier; Olivier Guillaud; Valérie Hervieu; Jean-Yves Sc 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB 👁 2 views

Recurrent hepatitis C after liver transplantation (LT) is a major problem, since up to 30% of patients develop cirrhosis only 5 years after LT in the absence of antiviral therapy. The aim of this study was to examine the rate of progression of fibrosis and its associated risk factors in patients sub

Hepatitis C virus therapy in liver trans

Hepatitis C virus therapy in liver transplant recipients: Response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis

✍ Bruno Roche; Mylene Sebagh; Maria Laura Canfora; Teresa Antonini; Anne-Marie Roq 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 420 KB 👁 1 views

Antiviral therapy after liver transplantation (LT) using interferon (IFN) and ribavirin (RBV) can achieve a sustained virological response (SVR) rate ranging from 20% to 45%. The aims of our study were to assess efficacy and tolerability of therapy, effect on fibrosis progression and the importance